ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Nephrology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,430Medicare Part D Prescriptions Filled, Including Refills

Rank: 5 out of 226

$742K Total Retail Price of All Prescriptions

Rank: 22 out of 226

695 Patients Receiving at Least One Drug in Part D
71%Patients 65 Years and Older
58% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 695 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

6% of this provider’s 695 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 8,532 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $106 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 13.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
HYDRALAZINE HCL 912 632 10 1 5
AMLODIPINE BESYLATE 883 588 2 1
ALLOPURINOL 574 488 3 11
LISINOPRIL 538 329 4 3
CARVEDILOL 518 358 5 7
PRAVASTATIN SODIUM 398 313 6 30
CLONIDINE HCL 388 261 7 12
FUROSEMIDE 365 266 8 2
CALCITRIOL 351 307 9 8
FAMOTIDINE 343 197 10 35
LEVOTHYROXINE SODIUM 299 233 11 18
CALCIUM ACETATE 297 130 12 14
SIMVASTATIN 282 199 13 10
RENVELA 281 131 14 4
METOPROLOL TARTRATE 230 136 15 9
BUMETANIDE 229 120 16 63
LOSARTAN POTASSIUM 203 143 17 13
POTASSIUM CHLORIDE 195 170 18 25
DIOVAN 169 114 19 23
ATORVASTATIN CALCIUM 167 145 20 27
TRAMADOL HCL 159 117 21 28
PANTOPRAZOLE SODIUM 151 83 22 38
HYDROCHLOROTHIAZIDE 136 122 23 20
HYDROCODONE-ACETAMINOPHEN 124 66 S3 24 17
WARFARIN SODIUM 118 53 25 37
ATENOLOL 116 98 26 32
OMEPRAZOLE 106 53 27 16
GLIPIZIDE 103 99 28 58
SENSIPAR 95 32 29 6
ZOLPIDEM TARTRATE 88 52 30 29
DOXAZOSIN MESYLATE 87 35 31 19
ENALAPRIL MALEATE 86 77 32 69
GABAPENTIN 85 44 33 21
CRESTOR 81 63 34 42
BENAZEPRIL HCL 80 70 35 49
AMITRIPTYLINE HCL 61 29 R 36 93
METOPROLOL SUCCINATE 59 58 37 22
ISOSORBIDE MONONITRATE ER 59 34 37 45
KLOR-CON M20 59 54 37 41
AMIODARONE HCL 57 29 40 196
LANTUS 55 45 41 53
PREDNISONE 55 22 41 24
CLOPIDOGREL 55 36 41 44
DIGOXIN 52 36 44 98
ISOSORBIDE DINITRATE 52 34 44 134
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 24, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.